Literature DB >> 2573355

Non-NMDA glutamate receptor antagonist 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors.

T Honore1, J Drejeŕ, E O Nielsen, M Nielsen.   

Abstract

Binding of 3H-CNQX to rat cortical membranes is saturable and reversible. Apparently, 3H-CNQX binds to a single site with KD = 39 nM. However, studies using AMPA as inhibitor revealed a biphasic inhibition of 3H-CNQX binding. The results suggest that CNQX binds with the same affinity to two different sites. The molecular target size of 3H-CNQX binding (51.8 +/- 3.4 kD) is equivalent to the size of the high affinity 3H-AMPA binding sites, but different from the high affinity 3H-kainate binding sites. A monoexponential decay curve for the high energy radiation inactivation analysis of 3H-CNQX binding indicates that the two 3H-CNQX binding sites have the same molecular weight and therefore might be two different conformations of the same receptor. The standard excitatory amino acids quisqualate, AMPA and kainate have a different rank order of potency as binding inhibitors at the two conformations of the quisqualate receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573355     DOI: 10.1016/0006-2952(89)90615-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Physiological significance of high- and low-affinity agonist binding to neuronal and recombinant AMPA receptors.

Authors:  Markus Kessler; Erika Suzuki; Kyle Montgomery; Amy C Arai
Journal:  Neurochem Int       Date:  2008-03-08       Impact factor: 3.921

2.  Kainate binding to the AMPA receptor in rat brain.

Authors:  R A Hall; M Kessler; G Lynch
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

Review 3.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

4.  Channel gating kinetics and synaptic efficacy: a hypothesis for expression of long-term potentiation.

Authors:  J Ambros-Ingerson; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

5.  Perampanel reduces paroxysmal depolarizing shift and inhibitory synaptic input in excitatory neurons to inhibit epileptic network oscillations.

Authors:  Ya-Chin Yang; Guan-Hsun Wang; Ai-Yu Chuang; Shu-Wei Hsueh
Journal:  Br J Pharmacol       Date:  2020-09-28       Impact factor: 8.739

6.  Age-related functional changes of the glutamate receptor channels in rat Meynert neurones.

Authors:  N Akaike; J S Rhee
Journal:  J Physiol       Date:  1997-11-01       Impact factor: 5.182

7.  ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

Authors:  L Turski; A Huth; M Sheardown; F McDonald; R Neuhaus; H H Schneider; U Dirnagl; F Wiegand; P Jacobsen; E Ottow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain.

Authors:  L M Hawkins; K M Beaver; D E Jane; P M Taylor; D C Sunter; P J Roberts
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  N-methyl-D-aspartate receptors are transiently expressed in the developing spinal cord ventral horn.

Authors:  R G Kalb; M S Lidow; M J Halsted; S Hockfield
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  CNQX binding to non-NMDA glutamate receptors in canine cerebro-cortical crude synaptosomal membranes: pharmacological characterization and comparison of binding parameters in dogs with congenital portosystemic encephalopathy and control dogs.

Authors:  J E Maddison; W E Watson; G A Johnston
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.